Drug List

Octreotide

Sandostatin

Somatuline

Probuphine (Opioid Dependency)

Vivitrol (Alcohol / Opioid Dependency)

 

Fasenra

Nucala

Xolair

 

Aranesp

Epogen

Procrit

Bridion

Voraxaze

Aristada

Zyprexa Relp

Botox

Botox Cosmet

Dysport

Myobloc

Xeomin

Bethkis

Cayston

Kalydeco

Kitabix Pak

Orkambi

Pulmozyme

Symdeko

Tobi

Tobi Podhaler

Tobramycin

Bravelle

Cetrotide

Fertinex

Follistim

Follistim Aq

Ganirelix Ac

Gonal-F

Gonal-F Rff

Humegon

Menopur 

Novarel

Pergonal 

Pregnyl

Ovidrel

Repronex

Krystexxa

Advate

Adynovate

Afstyla

Alphanate

Alphanate 

Alphanine Sd

Alprolix

Amicar

Aminocapr Ac

Autoplex T 

Bebulin

Bebulin Vh 

Benefix

Bioclate 

Corifact

Eloctate

Factir Viii

Feiba

Feibra Nf

Feibra Vh

Genarc

Helixate

Helixate Fx 

Hemlibra

Hemofil M

Humate-P

Humate-P Hu

Idelvion

Ixinity 

Kogenate

Konyne 80 

Mononine

Novoseven

Novoseven Rt

Nuwiq

Profilnine

Proplex T

Rebinyn

Rixubis

Stimate

Tretten

Wilate

Xyntha

Xyntha Solof

Copegus

Daklinza

Epclusa

Harvoni

Intron

Intron A 

Intron-A

Mavyret

Moderiba

Olysio

Pegasys

Pegintron

Peg-Intron

Rebetol

Ribapak

Ribasphere

Sovaldi

Technivie

Vemlidy

Viekira Pak

Vosevi

Zepatier

Berinert

Cinryze

Firazyr

Kalbitor

Ruconest

Aveed

Eligard 

Firmagon

Leuprolide 

Lupaneta

Lupron

Lupron 6-Pk

Lupron Depot

Natpara

Supprelin

Supprelin La

Trelstar

Trelstar Dep

Trelstar La

Trelstar Mix

Vantas

Zoladex

Praluent

Repatha

Repatha Sure

Baygam

Bayhep B

Bayrho-D 

Bivigam

Carimune

Carmune Nf 

Cmv-Igiv

Cytogam

Flebogamma

Gamastan

Gamastan S/d

Gamimmune N

Gammaked

Gammagard

Gamunex-C

H-Big

Hep B Immune

Hepagam B

Hyperhep B

Hyperrho S/d

Hyprho-D

Hyprho-D Hu

Immune Globu

Hizentra

Hyqvia

Vivaglobin

Cimzia

Cimzia Prefl

Entyvio 

Renflexis

Simponi

Simponi Aria

Deferoxamin

Deferoxamine

Desferal

Jadenu

Aldurazyme

Cerdelga

Cerezyme

Elaprase

Fabrazyme

Kanuma

Vpriv

Austedo

Soliris

Aubagio

Avonex

Avonex Pen

Avonex Prefl

Betaseron  

Copaxone 

Extavia

Gilenya

Glatopa

Mintoxantrone

Novantrone

Ocrevus

Plegridy

Plegridy Pen

Rebif

Rebif Rebido

Tecfidera

Tysabri

Granix

Leukine

Neulasta

Neupogen

Zarxio

Afinitor

Afinitor Dis

Alecensa

Aromasin 

Bexarotene

Bosulif

Capecitabine  

Erivedge

Erleada

Exemestrane

Farydak

Gleevec  

Hypcamtin

Ibrance

Imatinib Mes

Inlyta

Kisqali

Kisqali 200

Kisqali 400

Kisqali 600

Mekinst

Mustargen

Nerlynx

Nexavar

Odomzo

Rydapt

Sprycel

Stivarga

Sutent

Tafinlar

Tarceva

Targretin

Tasigna

Temodar

Temozolomide

Topotecan

Trisonex

Tykerb

Vandetanib

Votrient

Vyxeos

Xalkori

Xeloda

Xtandi

Zelboraf

Zolinza

Zykadia

Zytiga

Adcetris

Alkeran

Aredia 

Arzerra

Avastin

Azacitidine 

Bendeka 

Camptosar

Dacogen

Decitabine

Darzalex

Empliciti

Erbitux

Evomela  

Fusilev 

Gazyva

Halaven

Herceptin

Intron

Intron A

Intron-A

Irinotecan

Istodax

Jevtana

Kadcyla

Keytruda

Kyprolis

Levoleucovor

Melphalan

Mitoxantrone

Oncaspar

Opdivo

Pamidronate

Perjeta

Portrazza

Proleukin

Rituxan

Sylatron

Tecentriq

Temodar

Temozolomide

Thyrogen

Torisel

Treanda

Valstar

Vectibix

Velcade

Vidaza

Xgeva

Yervoy

Yondelis

Zometa

Euflexxa 

Gel-One

Genvisc 850

Hyalgan 

Hymovis

Monovisc

Orthovisc

Supartz

Supartz Fx

Synvisc

Synvisc One

Zilretta

Boniva

Forteo

Ibandronate

Prolia

Reclast

Tymlos

Cosentyx

Cosentyx Pen

Enbrel

Enbrel Srclk

Humira

Humira Pedia

Humira Pen

Inflectra

Otezla

Otrexup

Rasuvo

Remicade

Renflexis

Siliq

Stelara

Tremfya

Adcirca

Revatio

Sildenafil

Eylea

Lucentis

Acetemra

Enbrel

Enbrel Srclk

Humira

Humira Pedia

Humira Pen

Inflectra

Kevzara

Orencia

Otrexup

Rasuvo

Remicade

Renflexis

Rituxan

Xeljanz

Xeljanz Xr

Synagis

Buphenyl

Phenylbutyra

Pipeline Report

The AcariaHealth Pipeline Report is a quarterly publication, provided by Envolve Pharmacy Solutions, created to help clients prepare for shifts in pharmacy benefit management. This report includes updates across multiple disease states, highlighting recent and anticipated drug approvals, key changes in the biosimilar agent landscape, and notes on recent and anticipated generic product launches.

Click below to access the latest Pipeline Report.